RecruitingNot ApplicableNCT07122336
Optimized Ablation of the Posterior Wall in Persistent Atrial Fibrillation
Sponsor
Shanghai Chest Hospital
Enrollment
384 participants
Start Date
Jul 16, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The design of this study is an intervention, randomized, controlled study and contains three randomized groups:(1)PVI group;(2)PVI+PWI group;(3)PVI+PWI+EGM group.
Eligibility
Min Age: 18 YearsMax Age: 80 Years
Plain Language Summary
Simplified for easier understanding
This study is comparing two approaches to a heart procedure called catheter ablation for persistent atrial fibrillation (AFib) — an irregular heart rhythm that lasts more than 7 days. The study tests whether treating an additional area of the heart (the posterior wall) during ablation improves outcomes.
**You may be eligible if...**
- You are 18 years or older
- You have persistent AFib (episodes lasting at least 7 days but no more than 3 years)
- This would be your first ablation procedure for AFib
- Your AFib causes symptoms and hasn't responded well to medications
**You may NOT be eligible if...**
- You have had a previous ablation for AFib
- You have a blood clot in your heart (left atrial appendage)
- You have significant structural heart disease or advanced heart failure
- You have had a recent heart attack or major heart surgery
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREPVI
PVI
PROCEDUREPWI
PWI
PROCEDUREEGM
EGM
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07122336
Related Trials
PVI Alone vs PVI and Linear Ablation for Persistent Atrial Fibrillation (PROMPT AF II)
NCT071069701 location
Evaluation of the Efficacy of Pulmonary Vein Isolation by Pulsed-field Ablation in Persistent Atrial Fibrillation: a Multicenter Study With Follow-up by Implantable Cardiac Monitor
NCT069859011 location
Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation
NCT075752691 location
Feasibility Study of the FARAFLEX Mapping and PFA System
NCT065105564 locations
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
NCT0673553440 locations